Related Experiment Video

Updated: Aug 15, 2026

Cardiac Loading using Passive Left Atrial Pressurization and Passive Afterload for Graft Assessment
08:49

Cardiac Loading using Passive Left Atrial Pressurization and Passive Afterload for Graft Assessment

Published on: August 2, 2024

[Passive volume-reducing surgery in heart failure and dilated cardiomyopathy. Results from a pilot study account for

Anders Franco-Cereceda1, Mikael Runsiö, Jan Liska

  • 1Thoraxkliniken, Karolinska Universitetssjukhuset Solna. andfra@mbox.ki.se

Lakartidningen
|September 20, 2005
PubMed

Insights

The CorCap Cardiac Support Device (CSD) improved heart function and quality of life in dilated cardiomyopathy patients undergoing cardiac surgery. This polyester device offers a potential new treatment for heart failure.

Area of Science:

  • Cardiology
  • Biomedical Engineering

Context:

  • Dilated cardiomyopathy (DCM) and heart failure significantly impact cardiac function and patient well-being.
  • Conventional treatments for advanced heart failure often involve invasive cardiac surgery.

Purpose:

  • To evaluate the safety and efficacy of the CorCap Cardiac Support Device (CSD) in patients with dilated cardiomyopathy and heart failure.
  • To assess the impact of CSD implantation on cardiac dimensions, functional capacity, and quality of life.

Summary:

  • Twelve patients with dilated cardiomyopathy received the CorCap CSD, a polyester device, alongside cardiac surgery (coronary artery bypass grafting or mitral valve plasty in some cases).
  • A 12-month follow-up demonstrated progressive and sustained improvements in cardiac dimensions, functional status, and overall quality of life.
  • The CSD, applied alone or with conventional surgery, showed potential in reversing ventricular dilation and enhancing functional capacity in heart failure patients.

Impact:

  • The CorCap CSD shows promise as an adjunct or standalone therapy for managing dilated cardiomyopathy and heart failure.
  • This passive containment surgery may offer a novel approach to improving outcomes for specific heart failure patient populations.
  • Further research is warranted to identify optimal patient selection criteria for CSD therapy.

More Related Videos

A Model of Reverse Vascular Remodeling in Pulmonary Hypertension Due to Left Heart Disease by Aortic Debanding in Rats07:41

A Model of Reverse Vascular Remodeling in Pulmonary Hypertension Due to Left Heart Disease by Aortic Debanding in Rats

Published on: March 1, 2022

Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR07:24

Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR

Published on: April 8, 2013

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...